Medical College of Georgia

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1	Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients.	Ongoing, but not recruiting	Closed	AUY922	NCT00526045
1	A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors	Completed	Closed	HSP990	NCT00879905